1. Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families
- Author
-
Simona Petrucci, Lucia Ricciardi, Barbara Spanò, Enza Maria Valente, Tamara Ialongo, Alessandro Ferraris, Laura Serra, Marco Bozzali, Arianna Guidubaldi, and Anna Rita Bentivoglio
- Subjects
Pediatrics ,medicine.medical_specialty ,Levodopa ,medicine.diagnostic_test ,Parkinsonism ,Montreal Cognitive Assessment ,Magnetic resonance imaging ,Cognition ,medicine.disease ,Atrophy ,Neurology ,medicine ,Physical therapy ,Anxiety ,Apathy ,Neurology (clinical) ,medicine.symptom ,Psychology ,medicine.drug - Abstract
Background Mutations in the PINK1 gene are the second most frequent cause of autosomal recessive early-onset parkinsonism. Methods We evaluated five affected PINK1 homozygous and 14 heterozygous mutation carriers from two large Italian families over a 12-year follow-up period. Motor, nonmotor, cognitive, psychiatric, and behavioral profiles were systematically assessed. Four homozygotes and eight heterozygotes underwent magnetic resonance imaging. Results All homozygotes showed a mild progression of motor signs and a persistent excellent response to levodopa. All but one patient complained of nonmotor symptoms and sleep impairment. Three presented impulse control disorders and two anxiety and apathy. All obtained abnormal scores at Montreal Cognitive Assessment (MoCA) and in tests sensitive to frontal functions; one presented a global cognitive impairment. Three heterozygotes showed motor signs and were diagnosed as possibly affected. They had nonmotor symptoms and cognitive impairment, and two of them showed mild bilateral temporal atrophy. Five unaffected heterozygotes reported abnormal scores at MoCA and low performances at tests sensitive to frontal functions. Conclusion We expanded the phenotypic profile of PINK1-related parkinsonism, including psychiatric and cognitive features as part of clinical presentation. © 2014 International Parkinson and Movement Disorder Society
- Published
- 2014